DOH asked to explain preference for expensive COVID-19 treatment
Published May 6, 2021, 8:22 PM Deputy Speaker and 1Sagip Partylist Rep. Rodante Marcoleta has asked the Department of Health and other health professionals to explain their preference in prescribing Remdesivir notwithstanding the World Health Organization’s advisory against its use for people battling the deadly novel coronavirus disease (COVID-19). Marcoleta said officials of the DOH and the Food and Drug Administration should also make public disclosure of their links with the so-called Big Pharma, stressing that they should be forthright in telling the public which companies financed res...